ArticleTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2021
A look-back at convalescent plasma to treat COVID-19.
Article in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.European journal of internal medicine · 2022Trial
- Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India.Healthcare (Basel, Switzerland) · 2023Article
- COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2022Article
- SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2022Article
- Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2021Article
- COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2021Article
- Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2021Observational
- Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2021Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.